Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The main concerns are quality control and lack of long-term human data
Current evidence does not support TB-500 as a primary peptide for gastrointestinal repair
The drugmaker stated that the data from the Phase III trial was based on about 3,400 people with a body mass index (BMI) of or above 30 or people with a BMI of 27
In rodent models, it has shown promise in protecting gastrointestinal and neural tissues against various insults
US$ 29.71
US$ 29.50
US$ 20.27
